Influence of helicobacteriosis on the development of pancreatic cancer
I.V. Kolosovych, I.V. Hanol, B.H. Bezrodnyi, Y.O. Nesteruk
- Bogomolets National Medical University, Kyiv
DOI: https://doi.org/10.15407/fz71.04.066

Abstract
Helicobacter pylori is considered one of the possible risk factors for the development of digestive system
pathology in general and pancreatic cancer in particular. The aim of the work was to investigate the
pathogenetic relationship between helicobacteriosis and the risk of pancreatic cancer. The study was
based on the results of an examination of 64 people aged 43-83 years, who were divided into two groups:
the first group (comparison group, n = 34) – men and women without gastrointestinal pathology at the
time of examination and the second group (main group, n = 30) – patients with unresectable, metastatic
pancreatic head cancer, stage IV T1-4N0-2M1, complicated by obstructive jaundice. It was found that alcohol
consumption in an amount of ≥150 g/week significantly increases the relative risk of developing pancreatic
cancer by 2.3 (4.7; 1.5) times, and the presence of type II diabetes mellitus - by 2.5 (5.5; 1.6) times. When
screening patients for Helicobacter pylori, the results of the rapid test were positive in the main group in
86.7% of patients, in the comparison group – in 73.5% of patients. Comparison of the results of serological
examination revealed a significant difference in the content of immunoglobulin A to Helicobacter pylori in
the studied groups, a positive test result was observed in 90% of patients in the main group and in 58.8%
of patients in the comparison group. The content of immunoglobulin A to Helicobacter pylori in serum >19
U/ml can be considered as a probable risk factor for pancreatic cancer in patients who consume alcohol ≥150
g/week (sensitivity 85.7%, specificity 50%), or have type II diabetes (sensitivity 85.7%, specificity 53.9%).
Keywords:
pancreatic cancer; lifestyle; microbiota; Helicobacter pylori; risk factors
References
- Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):493-502. doi: 10.1038/s41575-021-00457-x
- Chen Y, Wu G, Zhao Y. Gut microbiota and alimentary tract injury. Adv Exp Med Biol. 2020;1238:11-22. doi: 10.1007/978-981-15-2385-4_2 I.V. Kolosovych, I.V. Hanol, B.H. Bezrodnyi, Y .O. Nesteruk 72
- Kolosovych IV , Hanol IV . Modern aspects of pathogenesis and diagnosis of acute pancreatitis. Fiziol Zh. 2023; 69(1): 84-97. DOI: CrossRef
- Kunovsky L, Dite P, Jabandziev P, Dolina J, Vaculova J, Blaho M, Bojkova M, Dvorackova J, Uvirova M, Kala Z, Trna J. Helicobacter pylori infection and other bacteria in pancreatic cancer and autoimmune pancreatitis. World J Gastrointest Oncol. 2021 Aug 15;13(8):835-44. doi: 10.4251/wjgo.v13.i8.835
- Korotkyĭ VM, Kolosovych IV. Pharmacotherapeutic aspects of early postoperative period in patients with complicated gastroduodenal ulcer. Klin Khir. 2002 Feb;(2):15-8. [Ukrainian].
- Sharndama HC, Mba IE. Helicobacter pylori: an up-to-date overview on the virulence and pathogenesis mechanisms. Braz J Microbiol. 2022 Mar;53(1):33-50. doi: 10.1007/s42770-021-00675-0
- Gardner TB. Acute pancreatitis. Ann Int Med. 2021 Feb;174(2):ITC17-ITC32. doi: 10.7326/AITC202102160
- Hirabayashi M, Inoue M, Sawada N, Saito E, Abe SK, Hidaka A, Iwasaki M, Yamaji T, Shimazu T, Tsugane S. Author Correction: Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A populationbased cohort study in a large Japanese population: the JPHC study. Sci Rep. 2020 Jul 28;10(1):12950. doi: 10.1038/s41598-020-69880-5
- Bezrodnyi BH, Kolosovych IV , Hanol IV , Cherepenko IV , Slobodianyk VP , Nesteruk YO. Comparison of the clinical effectiveness of hepaticojejunostomy and self-expanding metal stents for bypassing the bile ducts in patients with unresectable pancreatic head cancer complicated by obstructive jaundice. Wiad Lek. 2024;77(4):629-34. doi: 10.36740/WLek202404102
- Yang H, Guan L, Hu B. Detection and Treatment of Helicobacter pylori: Problems and advances. Gastroenterol Res Pract. 2022 Oct 22;2022:4710964. doi: 10.1155/2022/4710964
- Kolosovych IV . Helicobacter pylori and its role in the pathogenesis of diseases of the digestive system. Fiziol Zh. 2024; 70(5): 108-20. DOI: CrossRef fz70.05.108
- Permuth JB, Rahman S, Chen DT, Waterboer T, Giuliano AR. A Case control study of the seroprevalence of Helicobacter pylori proteins and their Association with Pancreatic Cancer Risk. J Pancreat Cancer. 2021 Sep 16;7(1):57-64.
- Wang L, Cao ZM, Zhang LL, Dai XC, Liu ZJ, Zeng YX, Li XY, Wu QJ, Lv WL. Helicobacter pylori and autoimmune diseases: involving multiple systems. Front Immunol. 2022 Feb 10;13:833424. doi: 10.3389/ fimmu.2022.833424
|